A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that the medications have similar gastrointestinal safety profiles among those with T2D, providing clinicians with evidence to weigh the risks and benefits of these medications for their patients.
5-Year-Old Boy With IQ of 141 Reads 3,000 Books
At five years old, Arjun Vishal Prajapati has explored more than 3,000 books and developed a remarkable interest in science, mathematics and space. His story offers a thoughtful look at nurturing curiosity, supporting gifted learners and making room for a happy, balanced childhood.
0 Comments